Hoeflich et al. further demonstrated that combined treatment with the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 results in apoptosis and growth inhibition of BRAF and KRAS mutated cell lines and human xenograft tumor models [40]. This evidence concerns the gene KRAS and neoplasm.